Worth Watching Stocks: Chevron Corporation (NYSE:CVX), China Finance Online Co. (ADR) (NASDAQ:JRJC), Harris Corporation (NYSE:HRS), Retrophin (NASDAQ:RTRX), Pfizer Inc. (NYSE:PFE)


On Tuesday shares of Chevron Corporation (NYSE:CVX) closed at $104.20. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as -1.73%. Chevron Corporation (NYSE:CVX) announced that its subsidiary, Unocal Myanmar Offshore Co., Ltd., has entered into a Production Sharing Contract (PSC) with Myanma Oil & Gas Enterprise (MOGE), the national oil and gas company, to explore for oil and gas in the Rakhine Basin.

China Finance Online Co. (ADR) (NASDAQ:JRJC) in last trading activity decreased -26.01% to close at $4.58. Company weekly performance is -18.94% while its quarterly performance stands at -24.92%. China Finance Online Co. (ADR) (NASDAQ:JRJC) is -61.45% away from its 52 week high. China Finance Online Co. Limited (NASDAQ:JRJC) announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2014. Net revenues were $18.8 million, compared with $26.5 million in the fourth quarter of 2013. Revenues from financial services were $13.3 million, compared with $20.4 million in the fourth quarter of 2013.

On last trading day Harris Corporation (NYSE:HRS) decreased -1.40% to close at $71.87. Its volatility for the week is 1.75% while volatility for the month is 1.41%. HRS’s EPS growth for past 5 years was 16.50%. Harris Corporation (NYSE:HRS) monthly performance is -7.35%. Harris Corp. (NYSE:HRS)‘s stock had its “buy” rating reissued by Zacks in a report released on Monday.

Retrophin, Inc. (NASDAQ:RTRX) has 19.60% insider ownership while its institutional ownership stands at 82.90%. In last trading activity company’s stock closed at $23.00. The U.S. FDA approved Retrophin Inc’s (NASDAQ:RTRX) Cholbam (cholic acid) for pediatric and adult patients with bile acid synthesis disorders, and for paroxysmal disorders.

On last trading day Pfizer Inc. (NYSE:PFE) decreased -1.51% to close at $34.52. Its volatility for the week is 1.76% while volatility for the month is 1.50%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is 0.38%. Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company announced that they are preparing to resume the phase 3 clinical programme for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with their collaboration agreement.


Leave a Reply

Your email address will not be published. Required fields are marked *